Home › Diffuse Scleroderma
Pag-aaral pangklinika para sa Diffuse Scleroderma na nagre-recruit sa U.S.
22 pag-aaral para sa Diffuse Scleroderma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY8 pag-aaral
- Ann Arbor, MI7 pag-aaral
- Chicago, IL7 pag-aaral
- Los Angeles, CA6 pag-aaral
- Durham, NC6 pag-aaral
- Houston, TX5 pag-aaral
- Boston, MA5 pag-aaral
- Baltimore, MD5 pag-aaral
- Philadelphia, PA4 pag-aaral
- Kansas City, KS4 pag-aaral
- Pittsburgh, PA4 pag-aaral
- New Orleans, LA4 pag-aaral
- Charleston, SC3 pag-aaral
- Charlotte, NC3 pag-aaral
- Phoenix, AZ3 pag-aaral
- Jacksonville, FL3 pag-aaral
- Aurora, CO3 pag-aaral
- Cedar Rapids, IA3 pag-aaral
- Plantation, FL3 pag-aaral
- Dallas, TX3 pag-aaral
Ayos sa estado
- Arizona5 pag-aaral
- California9 pag-aaral
- Colorado3 pag-aaral
- Florida8 pag-aaral
- Illinois8 pag-aaral
- Iowa3 pag-aaral
- Kansas5 pag-aaral
- Louisiana4 pag-aaral
- Maryland5 pag-aaral
- Massachusetts5 pag-aaral
- Michigan7 pag-aaral
- Minnesota4 pag-aaral
- New Jersey3 pag-aaral
- New York9 pag-aaral
- North Carolina8 pag-aaral
- Pennsylvania6 pag-aaral
- South Carolina3 pag-aaral
- Tennessee4 pag-aaral
- Texas7 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06470048Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT04797286EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07287670A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Nagre-recruitPhase 1
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07085104A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05878717A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06925542Platform Clinical Study for Conquering Scleroderma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Nagre-recruitPhase 2/3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06328777Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Nagre-recruitPhase 2
Edad 8 hanggang 60 · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT03630211A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Nagre-recruitPhase 1/2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06991114Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT07090226A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07115745US Zamto-cel Autoimmune Diseases
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT06708845A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 31, 2026 · NCT07047690Rheumatology Patient Registry and Biorepository
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT04402086The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 8, 2026 · NCT06675344Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Kababaihan · Na-update Ene 8, 2026 · NCT03276923Scleroderma Registry & Repository at the Hospital for Special Surgery
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 26, 2025 · NCT01656447Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update May 29, 2025 · NCT01793168Rheumatology Diet Study
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT06339957Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.